Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsinfectious-diseases

Paeds SAQs · infectious-diseases

Varicella and herpes zoster — formative SAQs

Formative SAQs on varicella and herpes zoster: the risk-stratified management of an immunocompromised child with primary varicella, and the assessment and public-health management of a pregnant adolescent with a varicella contact — covering host-risk tiering, antiviral therapy, isolation, exclusion, notification, post-exposure prophylaxis and prevention.

20 marks30 min4 min readVerification in progress

Target exams

RACP General PaediatricsRACP DCEMRCPCH ClinicalABP General Pediatrics
On this page
Study tools

Target exams

RACP General PaediatricsRACP DCEMRCPCH ClinicalABP General Pediatrics
Prompt
Varicella and herpes zoster (chickenpox and shingles)

SAQ 1 (10 marks)

A 6-year-old boy receiving maintenance chemotherapy for acute lymphoblastic leukaemia is brought to the emergency department with a 24-hour history of fever and a generalised vesicular rash that began on the trunk. His sibling had chickenpox two weeks ago. The child is febrile to 38.9 °C, tachypnoeic, and has lesions in all stages across his trunk and face. [1]

Question: Outline the immediate and stepwise management of this child, including risk stratification, investigations, treatment, infection control and the public-health response. (10 marks) [3]

Model answer

Risk stratification and disposition (2 marks). This child is a high-risk host — an immunocompromised patient on chemotherapy — and primary varicella in this group carries a real risk of disseminated, fulminant disease. Admit promptly, and have a low threshold for a monitored bed or PICU involvement given his tachypnoea. The host-risk tier is the organising principle: he needs urgent intravenous aciclovir, not the supportive default applied to a healthy child. [1] [3]

Investigations (2 marks). Confirm with PCR of vesicle fluid or a lesion-base swab, which is the test of choice for atypical, severe or high-risk cases, and which can distinguish wild-type from vaccine-strain virus. Given his tachypnoea, request a chest X-ray to look for varicella pneumonia, and check liver function tests and a coagulation screen to assess for hepatitis and disseminated disease. Do not delay treatment while waiting for results. [1]

Treatment (3 marks). Start intravenous aciclovir promptly without waiting for PCR confirmation when the clinical picture is compelling — delaying antiviral therapy in a host who cannot contain the virus is the avoidable error. Maintain hydration carefully to protect against aciclovir-induced nephrotoxicity. If pneumonia, secondary bacterial infection or invasive group A streptococcal disease emerges, add the appropriate targeted therapy — antibiotics covering streptococcus and staphylococcus including clindamycin for toxin suppression, and surgical review for necrotising fasciitis. Paracetamol for fever; never aspirin or salicylates because of the Reye syndrome association. [3] [1]

Infection control and public health (3 marks). Place the child under airborne plus contact precautions, because the virus spreads by both routes. Notify public health according to local requirements, because varicella is notifiable. Identify all high-risk contacts — pregnant women, neonates, immunocompromised individuals, and non-immune siblings or classmates — and arrange post-exposure prophylaxis. For contacts in whom the live vaccine is not contraindicated, give varicella vaccine within three to five days of exposure; for high-risk contacts in whom it is contraindicated (pregnant, neonate, immunocompromised), give varicella-zoster immune globulin. The encounter is not over until the contacts have been protected. [2] [5]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References5ShowHide
  1. [1]WHO Varicella and herpes zoster vaccines: WHO position paper, June 2014--Recommendations Vaccine, 2016.PMID 26723191
  2. [2]Marin M; Guris D; Chaves SS; Schmid S; Seward JF Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep, 2007.PMID 17585291
  3. [3]Klassen TP; Belseck EM; Wiebe N; Hartling L Acyclovir for treating varicella in otherwise healthy children and adolescents Cochrane Database Syst Rev, 2005.PMID 16235308
  4. [4]Chaves SS; Gargiullo P; Zhang JX; Civen R; et al Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005 J Infect Dis, 2008.PMID 18419385
  5. [5]Enders G; Miller E; Cradock-Watson J; Bolley I; Ridehalgh M Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases Lancet, 1994.PMID 7802767
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousVaccine-preventable disease outbreak response — formative SAQsinfectious-diseasesNextViral upper respiratory tract infection and the common cold — formative SAQsinfectious-diseases